Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$826K Sell
5,185
-25
-0.5% -$3.9K 0.42% 84
2014
Q3
$732K Buy
5,210
+1,300
+33% +$170K 0.35% 85
2014
Q2
$463K Buy
3,910
+955
+32% +$111K 0.23% 112
2014
Q1
$364K Sell
2,955
-25
-0.8% -$3.03K 0.18% 124
2013
Q4
$340K Sell
2,980
-25
-0.8% -$2.84K 0.16% 137
2013
Q3
$336K Buy
3,005
+600
+25% +$65.1K 0.19% 125
2013
Q2
$237K Buy
+2,405
New +$250K 0.14% 146

Other funds holding AMGN

Dominick & Dominick's AMGN Position: Q4 2014 in Review

Dominick & Dominick reduced its Amgen (AMGN) stake by 0.48% in Q4 2014, selling an estimated $3.9K and leaving 5,185 shares worth $826K. The position accounts for 0.42% of the portfolio, ranked #84.

Dominick & Dominick first reported a position in AMGN in Q2 2013 and has held it in 7 quarters since. 1,340 funds tracked by Wall St. Rank hold AMGN as of Q4 2014.

  • Dominick & Dominick held 5,185 shares of Amgen worth $826K as of Q4 2014.
  • Dominick & Dominick sold 25 Amgen shares in Q4 2014, an estimated $3.9K.
  • Amgen made up 0.42% of Dominick & Dominick's portfolio in Q4 2014, its #84 holding.
  • Dominick & Dominick first reported a position in Amgen in Q2 2013 and has held it in 7 quarters since.
  • 1,340 funds tracked by Wall St. Rank held Amgen as of Q4 2014.

Based on Dominick & Dominick's 13F filing for Q4 2014, filed 22 Jan 2015.